Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBS | P35520 | 1/20 | 0.50 |
| ▸ | EP300 | Q09472 | 1/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.47 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.47 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29186836 | 1.00 | CBS (0.50) | CBSEP300KAT2BKAT5KAT8 | |
| SCHEMBL31268006 | 0.86 | CBS (0.51) | CBSHPGD | |
| SCHEMBL9475529 | 0.86 | CBS (0.51) | CBSALOX12NPC1HPGDMAPK1 | |
| SCHEMBL29186837 | 0.86 | CBS (0.51) | CBSALOX12NPC1HPGDMAPK1 | |
| SCHEMBL3296522 | 0.83 | CBS (0.74) | CBSEP300KAT2BKAT5KAT8 | |
| SCHEMBL9472734 | 0.83 | CBS (0.54) | CBSNPC1HPGDMAPK1HTT | |
| SCHEMBL2467234 | 0.83 | CBS (0.74) | CBSEP300KAT2BKAT5KAT8 | |
| SCHEMBL9472748 | 0.83 | CBS (0.54) | CBSNPC1HPGDMAPK1HTT | |
| SCHEMBL20985452 | 0.83 | CBS (0.54) | CBSNPC1HPGDMAPK1HTT | |
| SCHEMBL31546163 | 0.83 | CBS (0.74) | CBSEP300KAT2BKAT5KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-5202355-A | Administering for diabetic neuropathy | TAKASAGO INSTITUTE FOR INTERDISCIPLINARY SCIENCE INC. (US) | 1993-04-13 | — | — | US | disclosed |